Other Populations

This issue brief summarizes analyses of Medicare fee-for-service data examining beneficiary use of tele-behavioral health services during 2019 and 2020. Results demonstrate that the number of Medicare beneficiaries receiving behavioral health care via telehealth increased dramatically during the COVID-19 public health emergency.

Health and human services policies and programs have wide-ranging effects on individuals and communities which can facilitate optimal health and well-being or impose harm, particularly for historically underserved communities.

This Issue Brief explores telehealth use for people and Medicare beneficiaries with disabilities and examines questions on the use of audio-only telehealth during the second and third years of the coronavirus disease 2019 (COVID-19) pandemic.

Effective January 1, 2023, the Inflation Reduction Act (IRA) eliminated cost sharing and deductibles for adult vaccines recommended by the Advisory Committee on Immunization Practices (ACIP) covered under Medicare Part D. In 2023, 10.3 million Medicare Part D enrollees received a recommended vaccine free of charge, which saved enrollees more than $400 million in out-of-pocket costs.

On April 25, 2024, HHS and DoL released recommendations, in the form of an Issue Brief, to improve data infrastructure on the workforce delivering home and community-based services (HCBS) in response to President Biden’s

This issue brief uses Medicare fee-for-service data to conduct illustrative analyses of primary care spending using a methodology that has been frequently used by policymakers and academics and can be applied to claims data.

This issue brief presents estimates of children’s average monthly gains in Medicaid and CHIP eligibility under a federal 12-month CE requirement. Characteristics and household income of children gaining eligibility under a national, 12-month CE policy are also presented.

The Affordable Care Act substantially transformed the market for non-group private health insurance, introducing new consumer protections and coverage standards and establishing Health Insurance Marketplaces.

In 2022, 43.3 million Medicare Part D enrollees (82 percent) filled 1.1 billion prescriptions for generic prescription drugs. While most enrollees filled at least one prescription for $2 or less, most (54 percent) paid more than $2 for at least one generic drug. Over 6 million enrollees filled at least one prescription for over $20.

The Inflation Reduction Act (IRA) is helping people with Medicare, including over 8 million Part D enrollees who reside in rural areas. This fact sheet outlines the potential impacts of the IRA’s key drug-related provisions for rural Medicare enrollees.